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Risk factor paradox in the occurrence of cardiac 
arrest in acute coronary syndrome patients
ORIGINAL ARTICLE
INTRODUCTION
Cardiovascular disease is the most important cause of premature death 
in western societies, and coronary heart disease the leading cause of death 
worldwide, according to World Health Organization.(1)
The main cardiovascular risk factors are well validated, and include, in 
particular, age, hypertension, diabetes, dyslipidemia, smoking and family 
Silvia Aguiar Rosa1, Ana Teresa Timóteo1, Marta 
Afonso Nogueira1, Adriana Belo2, Rui Cruz Ferreira1
1. Hospital de Santa Marta - Lisboa, Portugal.
2. Sociedade Portuguesa de Cardiologia - 
Coimbra, Portugal. Objective: To compare patients 
without previously diagnosed 
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with acute coronary syndrome.
Methods: This was a retrospective 
analysis of patients admitted with first 
episode of acute coronary syndrome 
without previous heart disease, who were 
included in a national acute coronary 
syndrome registry. The patients were 
divided according to the number of risk 
factors, as follows: 0 risk factor (G0), 
1 or 2 risk factors (G1 - 2) and 3 or 
more risk factors (G ≥ 3). Comparative 
analysis was performed between the three 
groups, and independent predictors of 
cardiac arrest and death were studied.
Results: A total of 5,518 patients 
were studied, of which 72.2% were male 
and the mean age was 64 ± 14 years. G0 
had a greater incidence of ST-segment 
elevation myocardial infarction, with 
the left anterior descending artery being 
the most frequently involved vessel, and 
a lower prevalence of multivessel disease. 
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(96% in Killip I; p < 0.001) and higher 
ejection fraction (G0 56 ± 10% versus G1 
- 2 and G ≥ 3 53 ± 12%; p = 0.024) on 
admission, there was a significant higher 
incidence of cardiac arrest. Multivariate 
analysis identified the absence of risk 
factors as an independent predictor of 
cardiac arrest (OR 2.78; p = 0.019). 
Hospital mortality was slightly higher 
in G0, although this difference was not 
significant. By Cox regression analysis, 
the number of risk factors was found 
not to be associated with mortality. 
Predictors of death at 1 year follow up 
included age (OR 1.05; p < 0.001), ST-
segment elevation myocardial infarction 
(OR 1.94; p = 0.003) and ejection 
fraction < 50% (OR 2.34; p < 0.001).
Conclusion: Even though the group 
without risk factors was composed 
of younger patients with fewer 
comorbidities, better left ventricular 
function and less extensive coronary 
disease, the absence of risk factors was an 
independent predictor of cardiac arrest.
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history.(2,3) These risk factors are incorporated in 
cardiovascular risk scores, which are useful tools in clinical 
practices for stratifying a patient’s risk of coronary artery 
disease and cardiovascular death and to guide the diagnosis 
and treatment approach.(3-5)
However, among patients admitted with acute 
coronary syndrome (ACS), there is a subgroup whose pre-
event stratification classifies them as low cardiovascular 
risk, due to the absence of traditional risk factors.(6)
Limited data are available regarding the magnitude, 
clinical features and outcome of ACS in individuals 
without risk factors.
The aim of the present study is to analyze the 
baseline characteristics, clinical presentation, laboratory, 
echocardiographic and angiographic characteristics and 
outcome of patients without previously diagnosed risk 
factors who were admitted with a first episode of ACS. 
With regards to hospital outcome, the presence of heart 
failure, cardiogenic shock and cardiac arrest was analyzed. 
In hospital and one-year follow up mortality was also 
evaluated, and was designated as the primary endpoint. 
The presence of cardiac arrest was considered as the 
secondary endpoint. The authors performed a comparison 
between groups according to the number of risk factors.
METHODS
This study was a retrospective analysis of patients 
admitted with first episode of ACS without previous heart 
disease, who were included in the National Portuguese ACS 
registry (Pro ACS) in each of the 33 participant cardiology 
departments, between 2010 and 2014. The Portuguese 
Registry of ACS received the approval and authorization 
from the National Committee of Data Protection 
(authorization number 3140/2010), and is registered at 
ClinicalTrials.gov with the identification number, NCT 
01642329. An informed consent form was also given to all 
patients. Patients who presented symptoms thought to be 
due to ACS and electrocardiographic changes consistent 
with and/or elevated levels of biomarkers of myocardial 
necrosis were included in the registry. This study includes 
patients with ST-segment elevation myocardial infarction 
(STEMI), non-ST-segment elevation myocardial 
infarction (NSTEMI) and unstable angina. STEMI was 
defined as a persistent ST segment elevation for more than 
30 minutes, and the remaining cases were considered non-
ST-elevation ACS, NSTEMI, if their troponin level was 
elevated above the reference limit, and unstable angina, if 
there were no changes in biomarkers. The diagnosis was 
defined by the physician at hospital admission.
The patients were divided into 3 groups, according to 
the number of risk factors, as follows: 0 risk factor (G0), 1 
or 2 risk factors (G1 - 2) and 3 or more risk factors (G ≥ 3). 
The following risk factors were analyzed: age > 55 years in 
men and > 65 years in women, hypertension, diabetes, 
dyslipidemia, smoking, family history of coronary artery 
disease. The presence of risk factors was based on the 
patients’ medical history.
In each patient, baseline clinical characteristics, 
including demographic characteristics and comorbidities, 
were collected. Laboratory data on admission, 
electrocardiographic and echocardiographic parameters 
were also analyzed.
The outcome variables studied were cardiac arrest (at 
the prehospital level or in-hospital) and in-hospital and 
one-year all cause mortality.
The study protocol is in accordance with the 
Declaration of Helsinki.
Statistical analysis
Statistical analysis was performed using dedicated 
software, Statistical Package for Social Sciences (IBM 
SPSS, Chicago, IL), v. 19. Continuous variables were 
expressed as the mean ± standard deviation, and categorical 
variable were expressed as percentages. Study groups were 
compared using ANOVA for continuous variables, and 
Pearson’s chi-square test for categorical measures.
Two multivariate logistic regression models were 
built to identify the predictors of two endpoints, cardiac 
arrest and hospital mortality. To perform each regression 
model, we considered the variables that were significantly 
associated with the endpoint (p < 0.100 at univariate 
analysis) and had clinical relevance. The variables that were 
included in the final model were selected by the Stepwise 
Forward method, considering Likelihood Ratio test. The 
estimated odds ratio was considered to assess risk. Since 
we considered some variables as continuous, the linearity 
of logit for each variable was tested by the method of 
fractional polynomials. Goodness of fit was evaluated by 
model calibration and classification accuracy. To test the 
model calibration, the Hosmer and Lemeshow test (HL) 
was used, and classification accuracy was assessed by area 
under the ROC curve (AUC) analysis.
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The predictors of death at one-year follow up were 
determined by Cox regression model. Once again, we 
considered variables that were significantly associated 
with the endpoint and had clinical relevance, and used the 
Stepwise Forward method considering Likelihood Ratio 
test to select variables. The estimated hazard ratio was 
considered to assess risk. The proportionality of the risks 
war assessed by analyzing the Schoenfeld residuals, and 
the functional form of a continuous variable was analyzed 
considering Martingale residuals.
95% confidence intervals (CI) were used, and a p-value 
< 0.05 was considered statistically significant.
RESULTS
During the study period, 5,518 patients were admitted 
with a first episode of ACS and with no previous heart 
disease (49.7% of all patients enrolled in ProACS registry 
in the same period), and were included in this analysis.
The majority of patients were male (72.2%), with a 
mean age of 64 ± 14 years. In total, 151 patients (2.7%) 
were included in G0, 2,858 (51.8%) in G1 - 2 and 2,509 
(45.5%) in G ≥ 3 (Figure 1).
The baseline characteristics of the three groups are 
presented in table 1. Patients in G0 were significantly 
younger, with lower ratio male/female when comparing 
with G1-2 and G ≥ 3. Patients without risk factors also 
presented significantly fewer comorbidities, particularly 
peripheral arterial disease, previous stroke and chronic 
kidney disease.
During acute events, an extensive blood analysis 
was performed. In G0, 7.1% of patients presented with 
admission blood glucose higher than 200mg/L, and 13.0% 
of patients had total cholesterol higher than 240mg/dL.
Regarding ACS clinical presentation (Table 2), G0 had 
a greater incidence of STEMI, but lower Killip class, heart 
rate and systolic blood pressure on admission.
Comparing G1 - 2 and G ≥ 3, echocardiography 
documented significantly less left ventricular systolic 
function impairment in G0, with a mean ejection fraction 
of 56 ± 10%. This fact is likely related to the lower 
incidence of heart failure during hospitalization in this 
group (Table 2).
The left anterior descending artery was the most 
frequently involved vessel in G0 patients, despite these 
individuals presenting with a lower incidence of multivessel 
coronary disease, compared with known risk factors 
patients. There was no significant difference in percutaneous 
coronary intervention between the three groups (Table 2).
During hospitalization, G0 patients presented a 
twofold higher incidence of cardiac arrest, when compared 
with the G1 - 2 and G3 groups (6.6% versus 3.0% versus 
2.7%; p = 0.021). However, G0 patients did not have a 
significantly higher hospital mortality (Table 2).
A logistic regression model was built to identify the 
predictors of cardiac arrest, including the absence of risk 
factors, STEMI, systolic blood pressure, heart rate, Killip 
class > I, creatinine at admission, previous and in-hospital 
medication, culprit artery (left main and left anterior 
Figure 1 - Study flowchart.
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Table 1 - Baseline clinical characteristics
Characteristics
G0 
(N = 151)
G1 - 2 
(N = 2,858)
G ≥ 3 
(N = 2,509)
p value
Male 64.20 73.50 71.10 0.014*
Age (years) 49 ± 8 62 ± 15 67 ± 12 < 0.001†
Body mass index (kg/m2) 26.7 ± 3.9 26.8 ± 4.2 27.8 ± 4.3 < 0.001†
Hypertension 0 40.6 88.2 < 0.001*
Diabetes 0 6.0 44.1 < 0.001*
Dyslipidemia 0 23.7 77.9 < 0.001*
Smoker 0 34.8 34.4 < 0.001*
Family history of coronary artery disease 0 4.5 11.0 < 0.001*
Peripheral arterial disease 0.7 1.8 3.9 < 0.001*
Previous stroke 1.3 4.2 9.2 < 0.001*
Chronic kidney disease 2.7 2.5 5.4 < 0.001*
Neoplasm 3.4 4.2 4.4 0.855*
Chronic obstructive pulmonary disease 2.1 3.8 4.8 0.079*
Chronic kidney disease: creatinine > 2.0mg/dL, hemodialysis or renal transplantation. * Chi-squared test; † ANOVA. Values are expressed as (%) and mean ± standard deviation.
Table 2 - Admission characteristics and hospital outcome
Characteristics
G0 
(N = 151)
G1 - 2 
(N = 2,858)
G ≥ 3 
(N = 2,509)
p value
Angina 95.4 92.1 90.6 0.027*
Dyspneia 0 2.5 3.7 0.004*
Syncope 2.0 2.2 2.3 0.966†
STEMI 57.6 54.3 47.3 < 0.001*
Killip class I 96.0 90.2 86.5 < 0.001*
Heart rate (bpm) 76 ± 18 76 ± 19 79 ± 19 < 0.001†
Sinus rhythm 95.4 93.2 91.5 0.028*
Systolic blood pressure (mmHg) 132 ± 22 136 ± 28 141 ± 31 < 0.001†
Hemoglobin on admission (g/dL) 14 ± 1.6 14 ± 1.8 13.8 ± 1.9 < 0.001†
Left ventricular ejection fraction 56 ± 10 53 ± 12 53 ± 12 0.024†
Culprit artery - left anterior descending artery 41.0 40.6 36.6 0.027*
Multivessel disease 16.3 39.7 51.5 < 0.001*
Percutaneous coronary intervention 70.0 72.7 70.4 0.164*
Heart failure 4.0 11.6 13.1 0.002*
Cardiogenic shock 1.4 3.5 3.6 0.355*
Cardiac arrest 6.6 3.0 2.7 0.021*
Mortality 4.0 3.4 3.5 0.917*
STEMI - ST segment elevation myocardial infarction; * Chi-squared test; † ANOVA. Values are expressed as (%) and mean ± standard deviation.
descending artery), percutaneous coronary intervention 
and left ventricular ejection fraction < 50%. This analysis 
identified the absence of risk factors as an independent 
predictor of cardiac arrest (OR = 2.78; 95%CI 1.19 - 
6.51; p = 0.019). The other independent predictors were 
STEMI (OR = 5.74; 95%CI 3.18 - 10.38; p < 0.001), 
higher heart rate (OR = 1.02; 95%CI 1.01 - 1.02; p < 
0.001), systolic blood pressure (OR = 0.99; 95%CI 0.98 
- 0.99; p < 0.001), Killip class > I (OR = 3.55; 95%CI 
2.27 - 5.56; p < 0.001) and nitrates administration during 
hospitalization (OR = 0.53; 95%CI 0.34 - 0.83; p = 
0.005). The model was well calibrated (HL: p = 0.097), 
and had good discriminant accuracy (AUC = 0.79; 95%CI 
0.76 - 0.82) (Table 3).
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Table 3 - Statistical analysis to determine the predictors of cardiac arrest
Variables Coefficient SE
Multivariate analysis Univariate analysis
p value* OR (95%CI) p value* OR (95%CI)
Risk factor 0† 1.022 0.434 0.019 2.78 (1.19 - 6.51) 0.007 2.57 (1.30 - 5.11)
Risk factors 1 - 2† 0.126 0.200 0.529 1.13 (0.77 - 1.68) 0.511 1.12 (0.81 - 1.54)
STEMI 1.748 0.302 < 0.001 5.74 (3.18 - 10.38) < 0.001 6.32 (4.02 - 9.94)
Heart rate 0.016 0.004 < 0.001 1.02 (1.01 - 1.02) < 0.001 1.01 (1.01 - 1.02)
SBP -0.013 0.003 < 0.001 0.99 (0.98 - 0.99) < 0.001 0.98 (0.97 - 0.98)
KK > 1 1.266 0.229 < 0.001 3.55 (2.27 - 5.56) < 0.001 4.17 (2.97 - 5.87)
Nitratesin-hospital -0.634 0.227 0.005 0.53 (0.34 - 0.83) < 0.001 0.43 (0.30 - 0.61)
SE - standard error; OR - odds ratio; 95%CI - 95% confidence intervals; STEMI - ST segment elevation myocardial infarction; SBP - systolic blood pressure; KK - Killip Kimball class. * Wald 
test; † comparing with 3 or more risk factors.
Table 4 - Statistical analysis to determine the predictors of hospital mortality
Variables Coefficient SE
Multivariate analysis Univariate analysis
p value* OR (95%CI) p value* OR (95%CI)
Risk factor 0† 0.862 1.056 0.414 2.37 (0.30; 18.76) 0.764 1.14 (0.49 - 2.65)
Risk factors 1 - 2† 0.028 0.204 0.892 1.03 (0.69; 1.53) 0.818 0.97 (0.72 - 1.30)
Age 0.068 0.009 < 0.001 1.07 (1.05; 1.09) < 0.001 1.10 (1.08 - 1.11)
STEMI 1.011 0.237 < 0.001 2.75 (1.73; 4.38) < 0.001 3.11 (2.22 - 4.35)
SBP -0.017 0.004 < 0.001 0.98 (0.98; 0.99) < 0.001 0.97 (0.96 - 0.97)
KK > 1 0.783 0.216 < 0.001 2.19 (1.43; 3.34) < 0.001 8.54 (6.32 - 11.53)
Beta-blockerin-hospital -0.927 0.225 < 0.001 0.40 (0.25; 0.61) < 0.001 0.13 (0.10 - 0.18)
ACEI/ARBin-hospital -0.922 0.240 < 0.001 0.40 (0.25; 0.64) < 0.001 0.12 (0.09 - 0.16)
No Cor/No PCI‡ 1.590 0.237 < 0.001 4.90 (3.08; 7.80) < 0.001 8.96 (6.52 - 12.29)
Cor/No PCI‡ 0.509 0.326 0.119 1.66 (0.88; 3.15) 0.830 0.83 (0.51 - 1.36)
LVEF < 50% 1.314 0.233 < 0.001 3.72 (2.36; 5.87) < 0.001 7.14 (4.75 - 10.71)
SE - standard error. OR - odds ratio; 95%CI - 95% confidence intervals; STEMI - ST Segment elevation myocardial infarction; SBP - systolic blood pressure; KK - Killip-Kimball class; BB - beta-
blocker; ACEI/ARB - angiotensin converting enzyme inhibitors/angiotensin II receptor blockers; Cor - coronary angiography; PCI - percutaneous coronary intervention, LVEF - left ventricular 
ejection fraction. * Wald test; † comparing with 3 or more risk factors; ‡ comparing to coronary angiography/percutaneous coronary intervention.
Hospital all-cause mortality was slightly higher in G0, 
although this difference was not significant (Table 2). 
By logistic regression, we conclude that the absence of 
risk factors was not an independent predictor of hospital 
mortality (OR = 2.37; 95%CI 0.30 - 18.76; p = 0.414). 
Independent predictors included STEMI (OR = 2.75; 
95%CI 1.73 - 4.38; p < 0.001), Killip class > I (OR = 
2.19; 95%CI 1.43 - 3.34; p < 0.001), no percutaneous 
coronary intervention (OR = 4.90; 95%CI 3.08 - 7.80; p < 
0.001) and left ventricular ejection fraction < 50% (OR = 
3.72; 95%CI 2.36 - 5.87; p < 0.001). The model was well 
calibrated (HL: p = 0.147), and had excellent discriminant 
accuracy AUC = 0.92; 95%CI 0.89 - 0.94) (Table 4).
At the one-year follow up, there was no significant 
difference in survival between the three groups (Figure 2). 
By Cox regression analysis, the number of risk factor was 
not found to be associated with mortality (HR = 0.78; 
95%CI 0.45 - 1.37; p = 0.393). The predictors of death 
at the one-year follow up were as follows: age (HR = 
1.05; 95%CI 1.03 - 1.06; p < 0.001), STEMI (HR 
= 1.94; 95%CI 1.25 - 3.02; p = 0.003) and ejection 
fraction < 50% (HR = 2.34; 95%CI 1.57 - 3.47; p < 
0.001) (Table 5).
DISCUSSION
In the ProACS registry, patients with no known risk 
factors previous to the index event represent less than 3% 
of the overall ACS population without previous coronary 
artery disease. This proportion is in line with previous 
published data, which also showed that about 2% of 
patients admitted with a first episode of ACS had no risk 
factor.(6) Surprisingly, in this study, the absence of risk 
factors was associated with higher incidence of cardiac 
arrest.
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Table 5 - Statistical analysis to determine predictors of death at the one-year follow up
Variables Coefficient SE
Multivariate analysis Univariate analysis
p value* OR (95%CI) p valor* OR (95%CI)
Risk factor 0 - 1† 0.244 0.286 0.393 0.78 (0.45; 1.37) 0.173 0.81 (0.59 - 1.10)
Age 0.046 0.009 < 0.001 1.05 (1.03; 1.06) < 0.001 1.09 (1.08 - 1.10)
STEMI 0.664 0.225 0.003 1.94 (1.25; 3.02) < 0.001 2.33 (1.80 - 3.01)
ACEI/ARBdischarge -0.598 0.227 0.008 0.55 (0.35; 0.86) < 0.001 0.18 (0.13 - 0.25)
BBdischarge -0.851 0.221 < 0.001 0.43 (0.28; 0.66) < 0.001 0.16 (0.11 - 0.22)
ASAdischarge -1.460 0.229 < 0.001 0.23 (0.15; 0.36) < 0.001 0.08 (0.06 - 0.11)
No Cor/No PCI‡ 0.784 0.248 0.002 2.19 (1.35; 3.56) < 0.001 6.95 (5.41 - 8.92)
Cor/No PCI‡ -0.251 0.323 0.439 0.78 (0.41; 1.47) 0.838 0.96 (0.67 - 1.38)
LVEF<50% 0.848 0.202 < 0.001 2.34 (1.57; 3.47) < 0.001 4.55 (3.44 - 6.02)
SE - standard error; OR - odds ratio; 95%CI - 95% confidence intervals; RF- risk factors; STEMI - ST Segment elevation myocardial infarction; ACEI/ARB - angiotensin converting enzyme 
inhibitors/Angiotensin II receptor blockers; BB - beta-blocker; ASA - acetylsalicylic acid; Cor - coronary angiography; PCI - percutaneous coronary intervention, LVEF - left ventricular ejection 
fraction. * Wald test; † comparing with 3 or more risk factors; ‡ comparing to coronary angiography/percutaneous coronary intervention.
Figure 2 - Kaplan Meier survival curves for the three study groups.
In our population, patients without known risk 
factors were younger, had less comorbidities and better 
left ventricular systolic function. Even though this group 
of patients had less multivessel disease, they presented 
more often with STEMI and more frequently had the 
left anterior descending artery as the culprit. This fact has 
been described previously in other national registries, in 
which younger patients had higher STEMI incidence.(7,8) 
Our findings are in accordance with previous studies that 
showed a higher incidence of single-vessel disease in these 
patients.(9-11)
In our registry, the absence of risk factors was an 
independent predictor of cardiac arrest on presentation 
and hospitalization. However, hospital mortality was 
not significantly higher in G0 patients. Previous studies 
showed an inverse relationship between number of risk 
factors and hospital mortality. However, in a study by 
Canto et al., patients without risk factors were older, had 
more cardiogenic shock and higher Killip class, which is a 
different population from that in our registry.(12) Also, in 
a CRUSADE sub-study, an inverse association between 
number of risk factors and mortality was reported in 
the non-ST-segment elevation myocardial infarction 
population.(13)
We can postulate that patients with more risk factors 
and higher frequency of multivessel disease have more 
collateral blood flow, and this fact can limit infarct size 
and consequently, reduce hospital mortality and cardiac 
arrest. On the other hand, in the absence of risk factors, 
an ACS is less likely, and a lower suspicion can delay the 
diagnosis and effective intervention, increasing the risk of 
ventricular arrhythmia and mortality.
In contrast to hospital outcome, the one-year survival 
was higher in patients without risk factors. This fact likely 
reflects the younger age, better left ventricular function 
and fewer comorbidities of these patients.
Some of the patients without known risk factors might 
have another less conventional RF that was not assessed, 
since other risk factors is not systematically collected in 
the ProACS registry.
Patients without traditional risk factors can have, 
however, changes in glycemic metabolism, such as 
prediabetes and insulin resistance, which are correlated 
with the atherogenic process. This group of patients may 
have a sedentary lifestyle, with physical inactivity and/or 
poor nutrition and abdominal obesity that can contribute 
to disease progression. Depression was also previously 
described as a risk factor for ACS.(14,15) These patients can 
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also have atypical etiology, with hereditary thrombophilia 
and hyperhomocysteinemia being the most frequent 
etiologies described in previous studies.(9,16)
Little is known about the physiopathology of ACS in 
patients without traditional risk factors, and more studies 
are needed to understand these events and their correlation 
with poor hospital outcome.
Our study, based on a national registry with a large 
number of patients and recent data, accurately reflects 
clinical practice. Since the data was drawn from a registry, 
this research study does not have selection bias, and the 
study population dimension allowed the determination of 
outcome predictors.
Study limitations
A registry has the advantage of representing real 
life clinical practice, and the findings of the study are 
probably applicable to a large number of tertiary hospitals. 
However, only traditional risk factors were reported, and 
as we do not have information regarding other types of 
risk factors, we cannot conclude which atypical factors 
might be associated with the worsened outcome observed. 
Additionally, the diagnoses were performed by different 
physicians in each department, which could generate 
some bias. Furthermore, a minority of patients without 
Objetivo: Comparar pacientes admitidos com síndrome 
coronariana aguda sem prévia identificação de fatores de risco 
cardiovascular com pacientes que portavam um ou mais fatores 
de risco.
Métodos: Análise retrospectiva dos pacientes admitidos com 
o primeiro episódio de síndrome coronariana aguda sem cardio-
patia prévia, incluídos em um registro nacional de síndrome co-
ronariana aguda. Os pacientes foram divididos segundo o núme-
ro de fatores de risco: nenhum fator de risco (G0), um ou dois 
fatores de risco (G1 - 2) e três ou mais fatores de risco (G ≥ 3). 
Realizou-se uma análise comparativa entre os três grupos e se es-
tudaram os preditores independentes de parada cardíaca e óbito.
Resultados: O total apurado foi de 5.518 pacientes, 72,2% 
deles do sexo masculino, com média de idade de 64 ± 14 anos. 
O G0 teve uma incidência maior de infarto do miocárdio com 
elevação do segmento ST, sendo o vaso mais frequentemente 
envolvido a artéria descendente anterior esquerda, e menor 
prevalência de envolvimento de múltiplos vasos. Embora o G0 
tivesse uma classe Killip mais baixa (96% Killip I; p < 0,001) e 
maior fração de ejeção (G0: 56 ± 10% versus G1 - 2 e G ≥ 3: 53 
± 12%; p = 0,024) na admissão, houve incidência significante-
mente maior de parada cardíaca. A análise multivariada identi-
ficou ausência de fatores de risco como um fator independente 
para parada cardíaca (OR 2,78; p = 0,019). A mortalidade hos-
pitalar foi ligeiramente maior no G0, embora sem significância 
estatística. Segundo a análise de regressão de Cox, o número de 
fatores de risco não se associou com mortalidade. Os preditores 
de óbito em 1 ano de seguimento foram infarto do miocárdio 
com elevação do segmento ST (OR 1,05; p < 0,001) e fração de 
ejeção inferior a 50% (OR 2,34; p < 0,001).
Conclusão: Embora o grupo sem fatores de risco fosse com-
posto de pacientes mais jovens e com menos comorbidades, me-
lhor função ventricular esquerda e coronariopatia menos exten-
sa, a ausência de fatores de risco foi um preditor independente 
de parada cardíaca.
RESUMO
Descritores: Parada cardíaca; Fatores de risco; Síndrome 
coronariana aguda
known risk factors presented evidence of diabetes and 
dyslipidemia in blood samples collected during the acute 
event.
Finally, as the registry does not collect detailed 
information on the cause of death and thus, only the all-
cause mortality data was presented.
CONCLUSION
Even though the group with no risk factors was 
composed of younger patients with fewer comorbidities, 
better left ventricular function and less extensive coronary 
disease, the absence of risk factors was, in this study, an 
independent predictor of cardiac arrest. Even though 
patients without risk factors presented with a two times 
higher incidence of cardiac arrest during hospitalization, 
the absence of risk factors was not correlated with the 
occurrence of higher all-cause mortality. It is important to 
emphasize that despite these patients being less diseased 
at baseline, their hospital mortality was similar, and as 
such, these patients required the same effort in treatment 
approach. Importantly, at the one-year follow up, there 
was no significant difference in survival between study 
groups, and patients without risk factors presented a 
survival rate that was slightly better, reflecting the absence 
of important comorbidities.
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